Literature DB >> 20034587

Acquired immune response to defined Plasmodium vivax antigens in individuals residing in northern India.

Ratanesh K Seth1, Ajaz A Bhat, Donthamsetty N Rao, Sukla Biswas.   

Abstract

In this investigation, we evaluated the naturally acquired immune response to Plasmodium vivax stage-specific antigens in individuals of different age groups belonging to malaria endemic areas of northern India. Four synthetic peptides containing both B- and T-cell epitopes from P. vivax circumsporozoite protein, merozoite surface protein-1, apical membrane antigen-1 and gametocyte surface antigen-1 were used to determine both humoral and cellular immune responses. Immunity, in terms of antibody response and T-cell proliferation against these stage-specific peptides, has been observed in the study subjects. The results demonstrated age-dependent antibody response in this population. Forty two patients were diagnosed with P. vivax. There was a significant association (P=0.013) between number of antibody responders and recognition of stage-specific epitopes by antibodies. The antibody response to B-epitopes of P. vivax CSP, MSP1, AMA1 and GAM1 was associated with age; adults responded more frequently to these antigens than did younger children. In this population, 66% (201/304) cases showed seropositivity to all peptides and 13% (41/304) showed negative response. Peripheral blood mononuclear cells of more than 75% of individuals proliferated in response to stimulation by all four epitopes. In conclusion, the results demonstrated immunogenicity of the epitopes to P. vivax in population of this endemic zone. Copyright 2009 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20034587     DOI: 10.1016/j.micinf.2009.12.006

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  9 in total

1.  B cell epitope mapping and characterization of naturally acquired antibodies to the Plasmodium vivax merozoite surface protein-3α (PvMSP-3α) in malaria exposed individuals from Brazilian Amazon.

Authors:  J C Lima-Junior; J Jiang; R N Rodrigues-da-Silva; D M Banic; T M Tran; R Y Ribeiro; V S E Meyer; S G De-Simone; F Santos; A Moreno; J W Barnwell; M R Galinski; J Oliveira-Ferreira
Journal:  Vaccine       Date:  2011-01-06       Impact factor: 3.641

Review 2.  Progress towards the development of a P. vivax vaccine.

Authors:  Sai Lata De; Francis B Ntumngia; Justin Nicholas; John H Adams
Journal:  Expert Rev Vaccines       Date:  2021-03-04       Impact factor: 5.217

3.  Genetic diversity and population structure of genes encoding vaccine candidate antigens of Plasmodium vivax.

Authors:  Stella M Chenet; Lorena L Tapia; Ananias A Escalante; Salomon Durand; Carmen Lucas; David J Bacon
Journal:  Malar J       Date:  2012-03-14       Impact factor: 2.979

4.  Characterizing Antibody Responses to Plasmodium vivax and Plasmodium falciparum Antigens in India Using Genome-Scale Protein Microarrays.

Authors:  Swapna Uplekar; Pavitra Nagesh Rao; Lalitha Ramanathapuram; Vikky Awasthi; Kalpana Verma; Patrick Sutton; Syed Zeeshan Ali; Ankita Patel; Sri Lakshmi Priya G; Sangamithra Ravishankaran; Nisha Desai; Nikunj Tandel; Sandhya Choubey; Punam Barla; Deena Kanagaraj; Alex Eapen; Khageswar Pradhan; Ranvir Singh; Aarti Jain; Philip L Felgner; D Huw Davies; Jane M Carlton; Jyoti Das
Journal:  PLoS Negl Trop Dis       Date:  2017-01-24

5.  Temporal genetic changes in Plasmodium vivax apical membrane antigen 1 over 19 years of transmission in southern Mexico.

Authors:  Alejandro Flores-Alanis; Lilia González-Cerón; Frida Santillán; Cecilia Ximenez; Marco A Sandoval; René Cerritos
Journal:  Parasit Vectors       Date:  2017-05-02       Impact factor: 3.876

6.  Antibody responses within two leading Plasmodium vivax vaccine candidate antigens in three geographically diverse malaria-endemic regions of India.

Authors:  Sonal Kale; Chander P Yadav; Pavitra N Rao; Sneh Shalini; Alex Eapen; Harish C Srivasatava; Surya K Sharma; Veena Pande; Jane M Carlton; Om P Singh; Prashant K Mallick
Journal:  Malar J       Date:  2019-12-16       Impact factor: 2.979

7.  Differing patterns of selection and geospatial genetic diversity within two leading Plasmodium vivax candidate vaccine antigens.

Authors:  Christian M Parobek; Jeffrey A Bailey; Nicholas J Hathaway; Duong Socheat; William O Rogers; Jonathan J Juliano
Journal:  PLoS Negl Trop Dis       Date:  2014-04-17

8.  Naturally acquired immune responses to P. vivax merozoite surface protein 3α and merozoite surface protein 9 are associated with reduced risk of P. vivax malaria in young Papua New Guinean children.

Authors:  Danielle I Stanisic; Sarah Javati; Benson Kiniboro; Enmoore Lin; Jianlin Jiang; Balwan Singh; Esmeralda V S Meyer; Peter Siba; Cristian Koepfli; Ingrid Felger; Mary R Galinski; Ivo Mueller
Journal:  PLoS Negl Trop Dis       Date:  2013-11-14

9.  New highly antigenic linear B cell epitope peptides from PvAMA-1 as potential vaccine candidates.

Authors:  Raianna F Fantin; Vanessa G Fraga; Camila A Lopes; Isabella C de Azevedo; João L Reis-Cunha; Dhelio B Pereira; Francisco P Lobo; Marcela M de Oliveira; Anderson C Dos Santos; Daniela C Bartholomeu; Ricardo T Fujiwara; Lilian L Bueno
Journal:  PLoS One       Date:  2021-11-02       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.